Osaka, Japan

Kouhei Asano

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Osaka, JP (2010 - 2013)
  • Kanagawa, JP (2015)

Company Filing History:


Years Active: 2010-2015

Loading Chart...
4 patents (USPTO):

Title: Kouhei Asano: Innovator in Pharmaceutical Compounds

Introduction

Kouhei Asano is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of various diseases. With a total of 4 patents to his name, Asano's work is recognized for its potential impact on healthcare.

Latest Patents

Asano's latest patents include innovative compounds aimed at treating eicosanoid-associated diseases. These diseases encompass a range of conditions such as atherosclerosis, diabetes, obesity, and cancer. His inventions focus on compounds that exhibit superior pharmacological action and physicochemical properties. Another notable patent involves heterocyclic compounds that serve as pharmaceutical agents for treating circulatory and metabolic diseases, as well as central nervous disorders.

Career Highlights

Kouhei Asano is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda has allowed him to further his research and development efforts in creating effective treatments for various health conditions.

Collaborations

Asano collaborates with esteemed colleagues, including Takanobu Kuroita and Hideyuki Igawa. Their combined expertise contributes to the advancement of pharmaceutical innovations and enhances the potential for successful outcomes in their research.

Conclusion

Kouhei Asano's contributions to the field of pharmaceuticals through his innovative patents highlight his dedication to improving healthcare. His work continues to pave the way for new treatments that can significantly benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…